Ambolin
Ambroxol Hydrochloride BP
Ambolin Syrup: Each 5 ml syrup contains 15 mg Ambroxol hydrochloride BP.
Ambolin Paediatric Drops: Each ml drop contains Ambroxol hydrochloride BP 6 mg.
Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, Inflammatory diseases of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.
Average daily dose (preferably after meal)
0-6 months old : 0.5 ml 2 times a day
6-12 months old : 1 ml 2 times a day
1-2 years old : 1.25 ml 2 times a day
2 -5 years old : 2.5 ml ( 1/2 teaspoonful) 2-3 times a day
5 – 10 years old : 5 ml (1 teaspoonful) 2-3 times a day
10 years old and adults : 10 ml (2 teaspoonful) 3 times a day
Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.
Teratogenic and fetal toxicity studies have shown no harmful effect of Ambolin. However, it is advised not to use it in pregnancy, especially during the 1st trimester. Safety during lactation has not been established yet.
Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema has been reported.
Ambolin should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.
Ambroxol should not be taken simultaneously with antitussives (e.g. Codeine) because phlegm, which has been liquefied by Ambroxol might not be expectorated.
Protect from direct light exposure. Store in dry place at a temperature not exceeding 30°C. Keep out of the reach of children.
Ambolin Syrup: Each White PET bottle contains 100 ml syrup and a measuring cup.
Ambolin Paediatric Drops: Each HDPE bottle contains 15 ml paediatric drops and a calibrated dropper.
